rs193025205

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_024529.5(CDC73):​c.*12C>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00249 in 1,605,314 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0019 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0026 ( 4 hom. )

Consequence

CDC73
NM_024529.5 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.758

Publications

5 publications found
Variant links:
Genes affected
CDC73 (HGNC:16783): (cell division cycle 73) This gene encodes a tumor suppressor that is involved in transcriptional and post-transcriptional control pathways. The protein is a component of the the PAF protein complex, which associates with the RNA polymerase II subunit POLR2A and with a histone methyltransferase complex. This protein appears to facilitate the association of 3' mRNA processing factors with actively-transcribed chromatin. Mutations in this gene have been linked to hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism, and parathyroid carcinoma. [provided by RefSeq, Jul 2009]
CDC73 Gene-Disease associations (from GenCC):
  • hyperparathyroidism 2 with jaw tumors
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P, ClinGen
  • hyperparathyroidism 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • parathyroid gland carcinoma
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial isolated hyperparathyroidism
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 1-193250724-C-A is Benign according to our data. Variant chr1-193250724-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 221109.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00187 (283/151742) while in subpopulation NFE AF = 0.00331 (224/67652). AF 95% confidence interval is 0.00295. There are 0 homozygotes in GnomAd4. There are 126 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 283 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024529.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDC73
NM_024529.5
MANE Select
c.*12C>A
3_prime_UTR
Exon 17 of 17NP_078805.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CDC73
ENST00000367435.5
TSL:1 MANE Select
c.*12C>A
3_prime_UTR
Exon 17 of 17ENSP00000356405.4Q6P1J9
CDC73
ENST00000958309.1
c.*12C>A
3_prime_UTR
Exon 18 of 18ENSP00000628368.1
CDC73
ENST00000958310.1
c.*12C>A
3_prime_UTR
Exon 17 of 17ENSP00000628369.1

Frequencies

GnomAD3 genomes
AF:
0.00187
AC:
283
AN:
151626
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000411
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.000578
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00312
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00331
Gnomad OTH
AF:
0.00144
GnomAD2 exomes
AF:
0.00190
AC:
474
AN:
250010
AF XY:
0.00178
show subpopulations
Gnomad AFR exome
AF:
0.000186
Gnomad AMR exome
AF:
0.000117
Gnomad ASJ exome
AF:
0.000596
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00245
Gnomad NFE exome
AF:
0.00354
Gnomad OTH exome
AF:
0.00131
GnomAD4 exome
AF:
0.00255
AC:
3711
AN:
1453572
Hom.:
4
Cov.:
28
AF XY:
0.00247
AC XY:
1788
AN XY:
723606
show subpopulations
African (AFR)
AF:
0.000421
AC:
14
AN:
33266
American (AMR)
AF:
0.000157
AC:
7
AN:
44520
Ashkenazi Jewish (ASJ)
AF:
0.000307
AC:
8
AN:
26028
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39472
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86008
European-Finnish (FIN)
AF:
0.00274
AC:
146
AN:
53354
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5744
European-Non Finnish (NFE)
AF:
0.00309
AC:
3417
AN:
1105074
Other (OTH)
AF:
0.00198
AC:
119
AN:
60106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.436
Heterozygous variant carriers
0
169
338
506
675
844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
124
248
372
496
620
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00187
AC:
283
AN:
151742
Hom.:
0
Cov.:
32
AF XY:
0.00170
AC XY:
126
AN XY:
74166
show subpopulations
African (AFR)
AF:
0.000409
AC:
17
AN:
41526
American (AMR)
AF:
0.000263
AC:
4
AN:
15218
Ashkenazi Jewish (ASJ)
AF:
0.000578
AC:
2
AN:
3462
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.00312
AC:
33
AN:
10576
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00331
AC:
224
AN:
67652
Other (OTH)
AF:
0.00143
AC:
3
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00187
Hom.:
0
Bravo
AF:
0.00155
Asia WGS
AF:
0.000289
AC:
1
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
2
Parathyroid carcinoma (2)
-
-
1
Hyperparathyroidism 1 (1)
-
-
1
Hyperparathyroidism 2 with jaw tumors (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
4.6
DANN
Benign
0.52
PhyloP100
0.76
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs193025205; hg19: chr1-193219854; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.